iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
0.1304
-0.0318 (-19.61%)
At close: Apr 24, 2026, 4:00 PM EDT
0.1268
-0.0036 (-2.76%)
After-hours: Apr 24, 2026, 7:59 PM EDT
iSpecimen Revenue
In the year 2025, iSpecimen had annual revenue of $1.93M, down -79.24%. iSpecimen had revenue of $51.76K in the quarter ending December 31, 2025, a decrease of -96.49%.
Revenue (ttm)
$1.93M
Revenue Growth
-79.24%
P/S Ratio
2.01
Revenue / Employee
$275,571
Employees
7
Market Cap
3.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.93M | -7.36M | -79.24% |
| Dec 31, 2024 | 9.29M | -637.06K | -6.42% |
| Dec 31, 2023 | 9.93M | -474.12K | -4.56% |
| Dec 31, 2022 | 10.40M | -733.00K | -6.58% |
| Dec 31, 2021 | 11.14M | 2.95M | 36.06% |
| Dec 31, 2020 | 8.18M | 3.89M | 90.40% |
| Dec 31, 2019 | 4.30M | -96.47K | -2.20% |
| Dec 31, 2018 | 4.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inotiv | 514.03M |
| MDxHealth | 107.88M |
| Biodesix | 88.50M |
| Exagen | 66.58M |
| XWELL | 29.21M |
| Precipio | 24.05M |
| bioAffinity Technologies | 6.16M |
| Mainz Biomed | 537.08K |
ISPC News
- 1 day ago - iSpecimen Announces 1-for-40 Reverse Stock Split - Newsfile Corp
- 16 days ago - iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time - Newsfile Corp
- 5 weeks ago - iSpecimen Achieves Rapid Procurement Milestone for Influenza Research - Newsfile Corp
- 6 weeks ago - iSpecimen Transcript: AGM 2026 - Transcripts
- 6 weeks ago - iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching - GlobeNewsWire
- 2 months ago - iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete - Newsfile Corp
- 3 months ago - iSpecimen Transcript: AGM 2026 - Transcripts
- 3 months ago - E.F. Hutton & Co. Acts as Exclusive Placement Agent in iSpecimen Inc.'s ~$5.5 Million Private Placement - GlobeNewsWire